<VariationArchive VariationID="2500228" VariationName="NM_016222.4(DDX41):c.423del (p.Ile142fs)" VariationType="Deletion" Accession="VCV002500228" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-12" DateCreated="2023-05-07" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2523126" VariationID="2500228">
      <GeneList>
        <Gene Symbol="DDX41" FullName="DEAD-box helicase 41" GeneID="51428" HGNC_ID="HGNC:18674" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q35.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177511577" stop="177516961" display_start="177511577" display_stop="177516961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="176938577" stop="176943966" display_start="176938577" display_stop="176943966" Strand="-" />
          </Location>
          <OMIM>608170</OMIM>
          <Haploinsufficiency last_evaluated="2022-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DDX41">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-02-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DDX41">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_016222.4(DDX41):c.423del (p.Ile142fs)</Name>
      <CanonicalSPDI>NC_000005.10:177515939:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q35.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177515940" stop="177515940" display_start="177515940" display_stop="177515940" variantLength="1" positionVCF="177515939" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="176942941" stop="176942941" display_start="176942941" display_stop="176942941" variantLength="1" positionVCF="176942940" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>I142fs</ProteinChange>
      <ProteinChange>I16fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.177515943del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.177515943del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.176942944del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.176942944del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046846.2" sequenceAccession="NG_046846" sequenceVersion="2" change="g.6022del">
            <Expression>NG_046846.2:g.6022del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321732.2" sequenceAccession="NM_001321732" sequenceVersion="2" change="c.45del">
            <Expression>NM_001321732.2:c.45del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308661.1" sequenceAccession="NP_001308661" sequenceVersion="1" change="p.Ile16fs">
            <Expression>NP_001308661.1:p.Ile16fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321830.2" sequenceAccession="NM_001321830" sequenceVersion="2" change="c.45del">
            <Expression>NM_001321830.2:c.45del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308759.1" sequenceAccession="NP_001308759" sequenceVersion="1" change="p.Ile16fs">
            <Expression>NP_001308759.1:p.Ile16fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016222.4" sequenceAccession="NM_016222" sequenceVersion="4" change="c.423del" MANESelect="true">
            <Expression>NM_016222.4:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057306.2" sequenceAccession="NP_057306" sequenceVersion="2" change="p.Ile142fs">
            <Expression>NP_057306.2:p.Ile142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1386" sequenceAccession="LRG_1386">
            <Expression>LRG_1386:g.6022del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1386t1" sequenceAccession="LRG_1386t1">
            <Expression>LRG_1386t1:c.423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1386p1" sequenceAccession="LRG_1386p1" change="p.Ile142fs">
            <Expression>LRG_1386p1:p.Ile142fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016222.4(DDX41):c.423del (p.Ile142fs) AND DDX41-related hematologic malignancy predisposition syndrome" Accession="RCV003224847" Version="1">
        <ClassifiedConditionList TraitSetID="25690">
          <ClassifiedCondition DB="MedGen" ID="C4225174">DDX41-related hematologic malignancy predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-07-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016222.4(DDX41):c.423del (p.Ile142fs) AND DDX41-related disorder" Accession="RCV003410309" Version="4">
        <ClassifiedConditionList TraitSetID="90177">
          <ClassifiedCondition>DDX41-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-22" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-22" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-05-07" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25690" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="34872" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">DDX41-related hematologic malignancy predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0014809" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MPLPF</ElementValue>
                <XRef Type="MIM" ID="616871" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">DDX41-associated familial myelodysplastic syndrome and acute myeloid leukemia (MDS/AML) is characterized by an increased risk of myeloid neoplasms, lymphoid neoplasms, adult-onset single- or multiple-lineage cytopenias (including aplastic anemia), and red blood cell macrocytosis. The most common myeloid neoplasms include MDS, AML, and therapy-related myeloid neoplasms. Chronic myelomonocytic leukemia, chronic myeloid leukemia, and myeloproliferative neoplasms are less common. Lymphoid neoplasms include non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia.</Attribute>
                <XRef ID="NBK574843" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17899" />
                <XRef ID="17899" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34723452</ID>
                <ID Source="BookShelf">NBK574843</ID>
              </Citation>
              <XRef ID="488647" DB="Orphanet" />
              <XRef ID="C4225174" DB="MedGen" />
              <XRef ID="MONDO:0014809" DB="MONDO" />
              <XRef Type="MIM" ID="616871" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="90177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69927" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DDX41-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">DDX41-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7329974" SubmissionDate="2023-04-25" DateLastUpdated="2023-05-06" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="NM_016222.3:c.423delC|OMIM:616871" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003920868" DateUpdated="2023-05-06" DateCreated="2023-05-06" Type="SCV" Version="1" SubmitterName="Clinical Genomics Labs, University Health Network" OrgID="508271" OrganizationCategory="laboratory" OrgAbbreviation="UHN" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016222.3:c.423delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616871" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13174259</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7696685" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="30498760|DDX41-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004115895" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The DDX41 c.423delC variant is predicted to result in a frameshift and premature protein termination (p.Ile142Serfs*12). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in DDX41 are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DDX41" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016222.3:c.423delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DDX41-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7329974" TraitType="Disease" MappingType="XRef" MappingValue="616871" MappingRef="OMIM">
        <MedGen CUI="C4225174" Name="DDX41-related hematologic malignancy predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7696685" TraitType="Disease" MappingType="Name" MappingValue="DDX41-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="DDX41-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

